Functional Incremental Stepping in Place Test (F-IST) Validation
The purpose of this multi-site prospective study is to assess validity of a new step test called Functional-Incremental Stepping-in-place- Test (F-IST) compared to gold-standard cardiopulmonary exercise testing (CPET) and to physical function and health perception, respectively. The investigators will also assess test-
| Condition(s) | Intensive Care Medicine, Acute Care Medical |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The purpose of this multi-site prospective study is to assess validity of a new step test called Functional-Incremental Stepping-in-place- Test (F-IST) compared to gold-standard cardiopulmonary exercise testing (CPET) and to physical function and health perception, respectively. The investigators will also assess test-retest reliability of the F-IST. The investigators hypothesize that the F-IST will have high validity and test-retest reliability to be used in field testing environments such as the ICU. |
| Who can participate | Inclusion Criteria: -Currently able to walk with or without a walking aid, such as a cane or walker or rollator Exclusion Criteria: Pregnancy specifically related to cardiopulmonary testing * A recent significant change in resting ECG * Unstable angina * Uncontrolled cardiac dysrhythmias causing symptoms or hemodynamic compromise * Symptomatic severe aortic stenosis * Uncontrolled symptomatic heart failure * Acute pulmonary embolus or pulmonary infarction * Acute myocarditis or pericarditis * Suspected or known dissecting aneurysm * Acute systemic infection accompanied by fever, body aches, or swollen lymph glands * Left Main Coronary Stenosis * Moderate stenotic valvular heart disease * Electrolyte abnormalities * Severe arterial hypertension (\>200 systolic, \>110 diastolic) at rest * Ta |
| Ages | 18 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Kirby Mayer |
| Locations | Boca Raton, Florida, United States; Durham, North Carolina, United States |
| Start date | 2024-07-02 |
| NCT ID | NCT06853236 |
| Official listing | https://clinicaltrials.gov/study/NCT06853236 |